Marc Engelsgjerd

Marc Engelsgjerd, MD, currently serves as Vice President of Search & Evaluation at Royalty Pharma since October 2023. Prior experience includes a tenure at Bloomberg LP as a Senior Equity Research Analyst focused on biotechnology from January 2020 to September 2023. Engelsgjerd led the Oncology Practice at inThought Research from April 2011 to December 2019, where responsibilities encompassed analyzing industry trends and clinical trial data for biopharma clients. Previous roles include Director of Healthcare Research at Coleman Research Group, Vice President of Medical Strategy at 81qd, and Healthcare Principal at Reuters Insight, along with positions at Bank of America, UBS, Piper Jaffray, and Research Corporation Technologies, Inc. Educational qualifications include a Doctor of Medicine degree from the University of California, San Francisco, and a Bachelor of Science in Molecular & Cellular Biology from the University of Arizona.